The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I  by Qian, Feng et al.
Cell, Vol. 87, 979–987, December 13, 1996, Copyright 1996 by Cell Press
The Molecular Basis of Focal Cyst Formation
in Human Autosomal Dominant
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Feng Qian,* Terry J. Watnick,* Luiz F. Onuchic, de Almeida et al., 1995). Although all types of ADPKD
present with an identical profile of extrarenal manifesta-and Gregory G. Germino
tions (including liver cysts and aneurysms), PKD1 is theDepartment of Medicine, Division of Nephrology
most severe, with a lower median survival and a higherThe Johns Hopkins University School of Medicine
risk of progressing to end-stage renal disease (Ravine720 Rutland Street
et al., 1992).Baltimore, Maryland 21205
While unique mutations indisease-causing genes may
account for interfamilial variation, they cannot explain
why related individuals who presumably share a com-Summary
mon mutation have different clinical presentations. Se-
vere childhood cases of ADPKD born into families thatAutosomal dominantpolycystic kidney disease (ADPKD)
exhibit the classic adult presentation of the disease areis a common disease and an important cause of renal
dramatic examples of this phenomenon (Blyth and Ock-failure. It is characterized by considerable intrafamilial
enden, 1971; Kaariainen, 1987; Fick et al., 1993; Zerresphenotypic variation and focal cyst formation. To elu-
et al., 1993). Fick et al. (1994) argued that these familiescidate the molecular basis for these observations, we
are examples of anticipation and proposed that an un-have developed a novel method for isolating renal cys-
stable trinucleotide repeat might be responsible fortic epithelia from single cysts and have used it to show
these findings.that individual renal cysts in ADPKD are monoclonal.
Since these initial clinical observations were made,Loss of heterozygosity was discovered within a subset
the genes for PKD1 and PKD2 have been identified.of cysts for two closely linked polymorphic markers
PKD1 encodes a 14 kb mRNA that is derived from 46located within the PKD1 gene. Genetic analysis re-
exons that extend over z50 kb of genomic DNA (Thevealed that it was the normal haplotype that was lost.
European Polycystic Kidney Disease Consortium, 1994;This study provides a molecular explanation for the
The American PKD1 Consortium, 1995; Hughes et al.,focal nature of cyst formation and a probable mecha-
1995; The International Polycystic Kidney Disease Con-nism whereby mutations cause disease. The high rate
sortium, 1995). An unusual feature of the gene is thatat which “second hits” must occur to account for the
z70% of its length is replicated in at least three copieslarge number of cysts observed suggests that unique
clustered together on 16p13.1. The other loci, whichstructural features of the PKD1 gene may be responsi-
also are transcribed, have a sequence nearly identicalble for its mutability.
to that of PKD1 in their shared segments. The PKD1
gene product, polycystin, is 4302 amino acids in length
Introduction and is likely to be an integral membrane glycoprotein
that regulates cell–cell or cell–matrix interactions. PKD2
Autosomal dominant polycystic kidney disease (ADPKD) encodes a 5.4 kb mRNA within z68 kb of genomic DNA
is one of the most common inherited diseases of hu- (Mochizuki et al., 1996). The predicted protein of 968
mans; it is estimated to affect 1 in 1000 of the population amino acids has significant homology to the voltage-
(Gabow, 1993). Renal cysts are the major clinical fea- activated Ca21 channel a1E as well as to a portion of
tures of the disease and appear to increase in size and polycystin. It is thought to encode an integral membrane
number throughout the lifetime of an individual. This protein that may function as an ion channel or pore
process results in renal failure in approximately half of whose activity is regulated by polycystin. Neither gene
affected individuals by age 50 years. Although the renal has any trinucleotide repeats within its mRNA that are
lesion is the most prominent feature, ADPKD is a sys- >5 units in length, nor are any found within the complete
temic disorder with a variety of other manifestations gene sequence of PKD1.
including liver cysts, cerebral aneurysms, and a variety Mutation analysis of PKD1 has been greatly hindered
of cardiac valvular abnormalities. by high sequence similarity to its replicated loci. None-
ADPKD exhibits considerable variability with respect theless, the mutations reported to date for both PKD1
to both its renal and extrarenal manifestations. Genetic and PKD2 have been stable nucleotide substitutions,
heterogeneity is likely to account for at least some of deletions, or insertions and do not explain why family
these differences. Linkage studies have determined that members with the same germline mutation exhibit dra-
there are at least three forms of ADPKD. PKD1, which is matic phenotypic variability (Peral et al., 1995, 1996a,
most common and accounts for 85%–95% of all cases, 1996b; Mochizuki et al., 1996). In fact, Peral et al. (1996b)
maps to chromosome 16p13.3 (Reeders et al., 1985). recently reported a set of fraternal twins with the same
The second type, PKD2, which affects most of the re- germline nonsense mutation in PKD1 yet with remark-
maining families, maps to chromosome 4q13–23 (Kim- ably different phenotypes. One child had a severe infan-
berling et al., 1993; Peters et al., 1993). A small number tile-onset form of the disease, whereas the other had
of families have another form, which has not yet been no cysts at the age of 5 years. The authors suggested
mapped (Bogdanova et al., 1995; Daoust et al., 1995; that the difference in clinical presentation was most
likely due to the effect of a small number of genetic
modifying factors.*These authors contributed equally to this work and are listed in
alphabetical order. Although breeding experiments in mice with recessive
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Figure 1. Clonality Assay for Single Cysts
Derived from Kidney Donors JHU93 and
JHU273
(A) Cystic epithelia were isolated from 11 in-
tact cysts (1–11) from donor JHU93. Male ge-
nomic DNA (?) was added to an aliquot of
each cyst-derived DNA sample as well as
DNA isolated from the donor’s nucleated
blood cells. One half of each mix was di-
gested with HpaII and then used as template
for PCR using the androgen receptor primers
AR1 and AR2. The amplification products are
presented in lanes labeled 1. The other undi-
gested half of each mix was used as template
for a control amplification done in parallel us-
ing identical reaction conditions. The results
are presented in lanes labeled 2. The sym-
bols to the left of the figure identify the posi-
tion of the AR alleles of the donor (/) and
male control. Three bands are present in the
2 lanes of all samples except for that which
had only male DNA as template (?) and cyst
9, which yielded no products. All samples derived from cysts yielded a single band after digestion if the reaction was complete (cysts 2, 4,
5, 6, 8, and 11). In contrast, DNA from blood of the donor yielded two bands despite complete digestion with HpaII prior to PCR. The clonal
status of samples 1, 3, and 7 were deemed uninterpretable because of incomplete digestion.
(B) Sixteen intact cysts (C1–16) from donor JHU273 were analyzed using a protocol similar to that described above. Each mix of male- and
cyst-derived DNA was digested with HhaI rather than HpaII prior to amplification using AR1 and AR2. Both the final rinse (w) and fluid containing
the cyst-lining epithelial cells (c) were evaluated for each sample. For C1 and C2, the original cyst fluid (f) was similarly examined. A dilution
series of DNA prepared from nucleated blood cells of JHU273 was analyzed using an identical procedure (right). These data suggest that a
minimum of 2.5 ng of cyst DNA was used as template for each amplification. Assuming that the average cell contains z10 pg of DNA and
one tenth of the total yield of cyst DNA was used for each reaction, each sample was estimated to contain between 2500 and 500,000 cells.
cystic disease support a role for the effect of other loci in al., 1987). Recently, a polymerase chain reaction (PCR)–
based clonality assay has been developed that can bedisease expression, genetic background probably does
not explain all aspectsof phenotypic variability in human used for small quantities of template (Gilliland et al.,
1991). This method exploits methylation-sensitive re-ADPKD (Iakoubova et al., 1995). Even within a single
kidney, fewer than 1% of nephrons actually develop striction sites (HpaII and HhaI) close to the highly poly-
morphic (CAG)n repeat in the X-linked androgen receptorcysts, suggesting that cystogenesis is a focal process.
Histopathologic studies of ADPKD kidneys have con- gene. The methylation status of these sites correlates
with X-inactivation (Allen et al., 1992). Willman et al.firmed that cyst formation begins with the localized out-
growth of a tubule in any nephron segment, including (1994) used this approach to show the monoclonal na-
ture of histiocystosis X.We have modified this techniquesegments with different embryologic origins (Evan and
McAteer, 1992; Scha¨fer et al., 1994). These observations to determine the clonality of single cysts in ADPKD
kidneys.suggest that cyst formation is a two-step process and
that an inherited mutation at one of the ADPKD gene Initial studies using DNA prepared from large speci-
mens (>5 g) containing multiple cysts failed to detectloci is necessary but insufficient for cystogenesis.
We have hypothesized that the focal nature of cyst monoclonality (data not shown). We then attempted to
isolate the epithelialcells lininga single cyst using micro-formation in ADPKD probably holds clues to an under-
standing of the pathogenesis of this disorder. To study dissection. Again, most samples were polyclonal, but
histologic analysis revealed that the microdissectedthis process, we have developed a novel method for
isolating epithelial cells from single renal cysts that mini- specimens were in fact multilayered structures with mul-
tiple nonepithelial cellular elements (data not shown).mizes contamination by other cells and have used it to
show that renal cysts in ADPKD are monoclonal. We To circumvent these difficulties we adapted a method
previously used to study toad bladder epithelia (Handlerhave demonstrated loss of heterozygosity (LOH) within
individual cysts for two closely linkedpolymorphic mark- et al., 1979) and applied it to the isolation of cyst-lining
cells. In this method, the cyst remains intact during theers located within the PKD1 gene. Genetic analysis has
confirmed that it is the normal haplotype that is lost in entire procedure. EDTA injected into the cyst lumen is
used todissociate the epithelial cells from the underlyingsomatic tissues. This study provides a molecular expla-
nation for the focal nature of cyst formation and a proba- basement membrane, which serves as a natural barrier
to contaminating cells.ble mechanism whereby mutations cause disease.
Results of the clonality assay of cysts isolated from
two individuals with ADPKD are presented in Figure 1Results
as representative examples. Of the 11 samples that were
prepared from individual cysts of donor JHU93 (FigureRenal Cysts in ADPKD Are Monoclonal
X-chromosome inactivation has been commonly used 1A), two failed to yield sufficient product for analysis
(samples 9 and 10). The results of three other samplesto demonstrate the clonal nature of tumors (Fearon et
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were deemed uninterpretable because of incomplete
digestion (samples 1, 3, and 7). The remainder (samples
2, 4, 5, 6, 8, and 11) yielded a single product after diges-
tion. Samples prepared from 16 individual cysts of donor
JHU273 were similarly analyzed (Figure 1B). The clonal
status of three samples could not be determined be-
cause their final rinse solutions also yielded PCR prod-
ucts (C3 and C15) or because no PCR product was
detected (C5). Of the remaining 13 cysts, 11 (85%)
yielded a single PCR product after HhaI digestion. Only
2 of the 13 cysts (C6 and C14) yielded two products, and
in each instance the bands were of unequal intensity,
suggesting a clonal bias. Figure 2. Position of Intragenic PKD1 Polymorphisms Used to
Assay LOHA total of 76 renal cysts derived from 8 affected fe-
The PKD1 gene contains 46 exons and is bisected by a polypyrimi-males were analyzed for clonality, and 62 cysts (82%)
dine tract of z2.5 kb (hatched box). The replicated portion of thewere found to be monoclonal (Table 1). It is very likely
gene begins with the first exon and ends in intron 34 (stippled bar).that the actual percentage of monoclonal cysts is >82%.
The microsatellite KG8 lies within the 39UTR of the gene. EJ1 is aIn some samples, rinse solutions were not tested for
polymorphic locus located in exons 45–46. The primers used to
luminal contamination (Table 1). Later analyses revealed generate these markers and their relative positions are indicated.
that the rinse solution of approximately one half of the The PCR product that contains KG8 and EJ1 is approximately 1.6
kb in length and is generated using FQF28 and KG8R8.apparently polyclonal cysts yielded PCR products, sug-
gesting probable contamination (Figure 1). The small
number of cysts that are truly polyclonal may have re-
sulted from the fusion of two or more formerly neigh- band for KG8. Figure 3A is a representative example of
data using these markers. Two cysts from this kidneyboring monoclonal cysts.
(C8 and C14) were found to have LOH. A total of 46
cysts from four donors were evaluated with KG8, andAllelic Loss of a PKD1 Intragenic Microsatellite, KG8
It is possible that cysts may develop from a cluster 17% were found to be hemizygous for this marker (Table
1). At least two cyst preparations per donor had loss ofof cells sharing a common X-chromosome inactivation
status rather than from clonal expansion of a single a KG8 allele, and in each case it was the same allele.
progenitor cell. To prove that renal cysts are truly mono-
clonal and to investigate the molecular basis of clonality, Loss of a Second Closely Linked Marker, EJ1
We sought to confirm the KG8 results using a secondwe tested for LOH for PKD1 in individual cysts using
the microsatellite KG8 (Snarey et al., 1994). This marker marker that was either intragenic or immediately proxi-
mal to PKD1, but the closest known highly polymorphiclies within the39 untranslated region (39UTR) of the PKD1
mRNA (Figure 2). Two alleles were equally amplified in marker was at least 70 kb away. In the course of per-
forming mutation analyses, we discovered a polymor-most samples. In a subset, however, only a single band
was amplified. We included primers for the androgen phic locus, EJ1, in exons 45–46 that is located approxi-
mately 1.6 kb proximal to KG8 (Figure 2). It has at leastreceptor as an internal control. Two bands correspond-
ing to the androgen receptor alleles were equally ampli- three allelic variants (A1–A3) that can be detected using
heteroduplex analysis. We used this marker to test forfied in all samples, including those that had a single
Table 1. Summary of Clonality Assay and LOH for Single Renal Cysts from ADPKD Patients
Monoclonal Cysts
Number of Cysts Cysts with KG8 Allele EJ1 Allele
Patients Evaluateda Number % LOH Lost Lost
JHU93 6 6 100 ND ND ND
JHU188 9 7 78 ND NI NI
JHU244 12 10 83 ND NI NI
JHU245 10 5 50 C3 110 nt A1
C4 110 nt A1
JHU246 13 12 92 C4 106 nt A2
C14 106 nt A2
JHU288b 10 8 80 C8 104 nt NI
C14 104 nt NI
JHU273b 13 11 85 C8 106 nt A2
C12 No loss A2→A4
C14 106 nt A2
JHU304 3 3 100 ND ND NI
Total 76 62 82
a Number of cysts from which androgen receptor-specific PCR products could be amplified after HhaI or HpaII digestion.
b Samples for which the final rinses were tested for contamination.
ND, not determined; NI, not informative, nt, length in nucleotides.
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Figure 4. Haplotype Analysis of Donor JHU273
A 1.6 kb PCR fragment containing KG8 and EJ1 was amplifed from
blood and then cloned (Figure 2). Individual clones were assayed
for their respective KG8 (A) and EJ1 alleles (B). Clones wereassigned
an EJ1 allele based on mixing studies with unlabeled A1 (B) and A2
(data not shown). All clones contained either KG8 allele 110 bp and
EJ1 allele A1 (clones 1 and 3) or KG8 allele 106 bp and EJ1 A2 allele
(clones 2, 4, and 5). nt, length in nucleotides.
that cyst samples isolated from the same donor had
loss of an identical allele (Figure 3C). A total of 30 cysts
from three donors were evaluated with this marker, and
7 were found to have either a deletion or novel somatic
mutation involving this locus (Table 1).
Loss of the Unaffected Haplotype
The concordance between the KG8 and EJ1 data
strongly suggested that the lost alleles belong to theFigure 3. Loss of Heterozygosity for PKD1 Markers in Cysts from
same haplotype. We confirmed this hypothesis using aKidney Donor JHU273
method that exploited the physical proximity of the loci.(A) DNA isolated from cyst samples was used as template for PCR
A genomic fragment containing EJ1 and KG8 was ampli-using KG8 and the androgen receptor primers AR1 and AR2 (without
prior HhaI digestion). Sample numbers in this figure correspond to fied from the peripheral blood of each donor showing
those used in Figure 1. The numbers on the right indicate the lengths LOH for both markers using primers FQF28 and KG8R8
of the KG8 and androgen receptor alleles. In two cysts (C8 and (Figure 2). The products were cloned and the haplotype
C14), only one KG8 allele, 110 bp long, was amplified (top), whereas
of each was determined. A representative example oftwo bands were equally amplified by AR1 and AR2 (bottom). nt,
this analysis for JHU273 is shown in Figure 4. For eachlength in nucleotides.
donor, analysis of cloned genomic segments confirmed(B) Heteroduplex analysis of EJ1 amplified from the blood of JHU273
(lane 1) shows that the patient is informative at this locus. Sample that the lost KG8 and EJ1 alleles indeed belonged to
numbers in this figure correspond to those used in Figure 1. The the same haplotye (Table 1). No haplotype common to
majority of renal cysts assayed have the same pattern as lane 1. all donors was found to be lost in the samples.
C8 and C14, however, demonstrate LOH at this locus since hetero-
We next sought to determine whether it was the nor-duplex formation is no longer present. C12 shows a novel hetero-
mal or affected haplotype that was lost in cystic tissue.duplex pattern.
Linkage analysis using KG8 and 39HVR was performed(C) Mixing studies were performed to determine which EJ1 allele
remained in cyst samples with apparent LOH (C8 and C14) or a novel on the only two families available for testing. 39HVR was
heteroduplex pattern (C12). Samples with patterns representative of linked to the disease in these families, with maximum
blood (C2 and C15) were included as controls. Unlabeled EJ1 alleles lod scores of 1.34 (pedigree 1, Figure 5A) and 2.18 (pedi-
A1, A2, and A3 were mixed separately with radiolabeled EJ1 that had
gree 2, Figure 5B) at a recombination fraction of 0.0. Abeen amplified from each cyst and then analyzed for heteroduplex
positive lod score (1.93) was also obtained with KG8 information. The addition of A1 did not alter the preexisting hetero-
pedigree 2. While linkage of ADPKD to KG8 was onlyduplex patterns of any of the cysts, whereas the addition of A3
resulted in a novel pattern in cysts without LOH. Although mixing weakly positive in pedigree 1 (maximum lod score of
with A2 did not change the patterns for C2 and C15, it restored the 0.32), two-point analysis of 39HVR and KG8 favored the
control heteroduplex pattern in C8 and C14 and yielded a unique haplotype shown in Figure 5A (maximum lod score of
band in C12. These results suggest that A1 is present in all cysts,
0.99 at a recombination fraction of 0.0). These resultswhereas A2 has been lost from C8 and C14 and replaced by a novel
strongly sugest that it was the chromosome 16 haplo-allele in C12. A3 is missing from all cysts because this allele is not
type not associated with disease that was lost in cysticpresent in JHU273.
tissue (Figure 5).
A Novel Somatic MutationLOH in cysts from donors known to be polymorphic at
this locus. There was complete concordance between One cyst sample was discovered to have discordant
results with KG8 and EJ1. This sample (C12) did not havethe studies using KG8 and EJ1, with one exception (dis-
cussed below) (Figure 3B). All samples that lacked a loss of a KG8 allele but did have a unique heteroduplex
pattern with EJ1 (Figure 3). Mixing studies determinedKG8 allele also lacked one for EJ1. Mixing studies (see
Experimental Procedures) were used to demonstrate that the A2 allele of EJ1, which was lost in the other two
Molecular Basis of Focal Cyst Formation in PKD1
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Figure 5. Linkage Analysis of Two Polymorphic Markers Linked to
PKD1 in the Families of Donors JHU273 (A) and JHU246 (B)
PKD1 is linked to 39HVR and KG8 with maximum lod scores of 1.34
and 0.32, respectively, at a recombination fraction of 0.0 for both
markers in pedigree 1 (A). The posterior probability of linkage of the
disease in this family to PKD1 is >95%. Two-point analysis of 39HVR
Figure 6. A 2 bp Deletion in C12 (DC12) Creates a Novel MwoI Site
and KG8 favors the haplotype shown in (A). In pedigree 2 (B), the
(A) EJ1 was amplified from C12, and clones of two alleles (A1 andmaximum lod scores for 39HVR and KG8 are 2.18 and 1.93, respec-
A4) were identified. The sequence of the novel allele, A4, is showntively, at a recombination fraction of 0.0. The genotypes D,110 and
along with the corresponding sequence of A1. A4 contains a 2 bpA,110 segregate with ADPKD in pedigree 1 (A) and pedigree 2 (B),
deletion (underlined in A1) that creates a new MwoI site (arrow). Therespectively. In each kidney donor (arrows), it is the KG8 allele that
deletion was confirmed by analysis of two clones sequenced in bothdoes not segregate with disease which is lost in cystsdemonstrating
orientations.LOH. Affected genotypes are indicated by closed bars; deduced
(B) (Top) The MwoI restriction map of EJ1 A1 (M). An internal PCRgenotypes are shown in brackets. The pedigrees as shown do not
product of 172 bp was used to test for the presence of the novelinclude all family members. Triangles are used to protect the identity
MwoI site (M*). (Bottom) Comparison of the MwoI maps of thisof participants.
subfragment of A1 and A4. Cleavage at the new site is predicted
to result in two fragments of nearly identical length in A4.
(C) To confirm that the DC12 deletion was a somatic mutation, thecysts (C8 and C14) from this donor, had been replaced
172 bp subfragment was amplified from the following templates:by a novel allele (A4) in C12. We cloned both the A1
DNA isolated from peripheral blood of JHU273 (lanes 1 and 2) and
and A4 alleles of the EJ1 locus from this sample and cloned alleles A1 (lanes 3 and 4) and A4 (lanes 5 and 6) as well as
determined the sequence of the novel allele (Figure 6A). from the original EJ1 PCR product (lanes 7 and 8). Undigested
Comparison of the sequence of A4 to that of A1 revealed products (lanes 1, 3, 5, and 7) and products digested with MwoI
(lanes 2, 4, 6, and 8) were analyzed on a 4% Nusieve gel. As pre-two differences. The first is a 2 bp deletion (DC12) at
dicted, two indistinguishable bands of 80 and 81 bp are present inpositions 12,694–12,695 of the cDNA sequence (HUMP-
lanes 6 and 8 and absent in lanes 2 and 4. A 161 bp fragment isKD1A, GenBank accession number L33243). The DC12
also observed in the original EJ1 PCR product (lane 8). The 11 bp
deletion is predicted to cause a reading frameshift re- restriction fragment common to all could not be detected. The re-
sulting in a truncated protein. This mutation also creates sults were confirmed using an independently derived C12 EJ1 PCR
a new MwoI endonuclease restriction site not present product (data not shown).
in the sequence of either the A1 or A2 alleles of EJ1
(Figure 6B). This site was used to confirm the presence
of the deletion in the original C12 DNA sample (Figure
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6C). The donor’s blood DNA lacks the restriction site, examined. We cannot determine whether the two cysts
with LOH for KG8 had identical mutations or were inde-proving that the mutation was acquired and not present
in the donor’s germline. The second difference in the pendent events since they had identical X-chromosome
inactivation patterns. Cysts from other kidneys, how-A4 sequence is a C-to-T transition at position 12,617,
which has no effect on the protein sequence. This is the ever, that had a similar pattern of LOH for PKD1 markers
had different X chromosomes inactivated, suggestingsame sequence variant associated with the A2 allele,
suggesting that the DC12 deletion occurred on this that independent events had resulted in LOH (data not
shown). Formal proof of our hypothesis must await thebackground.
development of methods that can be used for mutation
analysis of the full length of the PKD1 gene.
Discussion The very high rate of somatic mutation predicted by
our model is surprising since no known dynamic ele-
A notable but unexplained clinical feature of all forms of ments have been identified within the genomic se-
ADPKD is the phenotypic variability exhibited by family quence of PKD1 and since the adult kidney is thought
members who share a common mutation. The focal na- to have a relatively low mitotic index. However, we have
ture of renal cysts is an extreme example of this variabil- previously reported an extremely unusual 2.5 kb poly-
ity since all renal tubular epithelial cells within a kidney pyrimidine tract within intron 21 that may be responsible
have an identical mutation. These features suggest that for the gene’s increased rate of mutation (The American
other factors are required for cyst formation. Identifica- PKD1 Consortium, 1995). Similar but much shorter ele-
tion of these other components may explain the patho- ments present within other genes have been shown to
genesis of the disease and possibly provide new ave- undergo triple-helix formation both in vitro (Young et al.,
nues for developing therapies. 1991) and in vivo (Rao et al., 1988). Wang et al. (1996)
To evaluate the molecular mechanisms responsible recently have shown that triplex formation induces
for cystogenesis, we developed a novel method for iso- mutagenesis in a mammalian cell culture system and
lating epithelial cells from individual cysts. This tech- demonstrated a requirement for excision and transcrip-
nique minimizes contamination from other cell types and tion-coupled repair in this process. The authors hypoth-
avoids biases resulting from the use of cultured cells. esized that formation of the triple helix causes a stall
We have used this approach to analyze multiple kidneys in transcription that triggers gratuitous and potentially
from females and have shown, using two independent error-prone repair. They proposed that naturally oc-
methods, that renal cysts in ADPKD are clonal in origin. curring triple helices may similarly trigger repair and
Our datasuggest that somatic mutationof thepreviously mutagenesis and thus constitute endogenous sources
normal PKD1 allele is the second, rate-limiting step in of genetic instability.
cystogenesis and is likely to account for the focal forma- We postulate that the polypyrimidine tract within
tion of renal cysts. The rate at which one acquires these PKD1 may cause ongoing errors in its transcription-
“second hits” probably plays a major role in determining coupled repair that result in a high frequency of somatic
the course of disease and probably explains much of mutation. This model can explain the multiplicity of sec-
its phenotypic variability. It may be speculated that a ond hits as well as the apparent development of new
similar two-hit mechanism may also be responsible for cysts throughout the lifetime of an individual. Likewise,
causing the extrarenal manifestations of PKD1. the genetic instability possibly associated with this un-
Loss of the normal allele of PKD1 in cystic tissue usual genomic structure may be responsible for the high
suggests a molecular recessive mechanism of disease incidence of PKD1 within the population. If this element
similar to that seen with numerous tumor suppressor is proven to be responsible for the gene’s mutability,
genes. If our model is correct, however, the frequency PKD1 will be the first example of a disease that results
of “second hits” in cystic epithelia must be extremely from this novel mechanism of somatic mutation.
high to account for the thousands of cysts that are ob- The indistinguishable clinical presentation of patients
served. This is in contrast to the small number of tumors with PKD2 suggests a two-step process in this disease
found in other inherited disorders of the kidney in which as well. Whereas the initial step is certainly a germline
somatic mutation of the normal allele is required for mutation of PKD2, the nature of the second event is not
disease. Wilms’ tumor (Huff et al., 1991) and von Hippel yet known. Presently it cannot be excluded that there
Lindau’s disease (Foster et al., 1994) are representative may be an uncharacterized unstable element hiding
examples. within the genomic structure of PKD2 that results in
Our data suggest that there is indeed a high rate of frequent somatic inactivation in a manner analogous to
somatic mutation in PKD1. This is best illustrated by that of PKD1. The relative infrequency of PKD2 argues
sample JHU273 (Table 1). Of the 13 cysts that were against this hypothesis, however. The phenotypic simi-
shown to be monoclonal, 2 had loss of alleles for KG8 larity of the disorders may offer an alternative hypothe-
and EJ1; 1 had a unique 2 bp deletion; and 8 had no sis. Investigators have postulated that the gene prod-
detectable mutation of the normal allele. The last group ucts of PKD1 and PKD2 may be interacting partners of
did not have a common X-chromosome inactivation pat- a common pathway. It has been suggested that the
tern, suggesting that they had arisen from at least two function of PKD1 may be to regulate the activity of PKD2
independent progenitor cells (Figure 1). Assuming that (Mochizuki et al., 1996). If this is correct, somatic inacti-
the somatic mutationsarose afterX-chromosome inacti- vation of PKD1 may be the second step that leads to
vation was completed, a minimum of four independent clonal expansion in PKD2 and possibly other forms of
ADPKD. This model predicts that the frequency withmutations must have occurred in the 13 cysts that were
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was added to each cyst DNA sample prior to PCR to control for thewhich cysts form in PKD1, PKD2, and PKD3 will be
completeness of HpaII or HhaI digestion. In most cyst samples,determined by the rate of somatic mutation of PKD1.
the male-specific product was not amplified after HpaII or HhaIThe identical number of renal cysts observed in the three
digestion, as expected.
disorders is consistent with this hypothesis.
In this study, we have determined that random inacti-
Loss of Heterozogosity Assay Using KG8
vation of the normal PKD1 allele in somatic tissue is the The microsatellite KG8 that is present in the 39UTR of PKD1 mRNA
likely molecular explanation for the observed clinical was used to distinguish the mutant and normal alleles (Snarey et
variability and the focal formation of renal cysts in the al., 1994). Cystic DNA samples served as template for PCR amplifi-
cation. PCR amplification was performed for 28 cycles using anmost common form of ADPKD. Both the high incidence
identical protocol as that used for the androgen receptor exceptof the disease in the population and the large number
that the reaction included a final concentration of 1 mM of each KG8of second hits that must occur to account for the num-
primer (KG8F8, 59-CTCCCAGGGTGGAGGAAGGTG-39 [bp 13,925–
ber of cysts observed suggest that unique features of 13,945; HUMPKD1A, GenBank accession number L33243] and
the PKD1 gene structure may be responsible for its KG8R8, 59-GCAGGCACAGCCAGCTCCGAG-39 [bp 14,014–14,034]),
mutability. Our data suggest a molecular recessive 5 nM 32P–end-labeled KG8F8, and 1.5 mM MgCl2. The PCR products
were diluted with 53 volume of sequencing loading buffer and sepa-mechanism of disease since both alleles are mutated in
rated in a 6% denaturing polyacrylamide gel. The dried gel wasrenal cysts. These findings have important implications
examined by autoradiography using X-Omat XAR film (Kodak) atfor investigators interested in developing models sys-
2808C overnight with an intensifying screen.
tems and suggest that treatment strategies directed at
replacement of polycystin may prevent cyst formation
Heteroduplex Analysisand end-stage renal disease.
Either 200 ng of genomic DNA (isolated from whole blood using
the Puregene kit) or 5 ml of cyst DNA was used as template for
amplification of a 540 bp product (EJ1) using primers FQF28Experimental Procedures
(59-CACGCCTTGCGTGGAGAG-39, 12,539–12,556; HUMPKD1A) and
FQR35 (59-ATGGGCCACGGGAAGATCC-39, 12,977–12,995). PCRPreparation of Cystic Epithelial Cells from a Single Cyst
was performed as follows: denaturation at 948C for 5 min; 35 cyclesCystic kidneys were processed within 24 hours of removal from the
of 948C for 30 sec, 628C for 30 sec, and 728C for 30 sec; and a finalpatient and were maintained at 48C. The surface of the cyst was
extension of 728C for 10 min. The total PCR volume was 30 ml usingfirst rinsed with PBS and then its contents were drained by needle
2 units of Taq DNA polymerase (Boehringer Mannheim), 0.2 ml dCTP,and syringe. The needle was left inserted in the cyst for the duration
and a final MgCl2 concentration of 1.5 mM.of the washing and incubation steps. The cavity of intact cysts was
Heteroduplex analysis was performed using Hydrolink Mutationrinsed a minimum of three times with Ca21- and Mg21-free PBS. The
Detection Enhancement gels (MDE, AT Biochem) following thelast rinse from some cysts was collected and stored on ice. PBS
manufacturer’s protocol. Urea was added to the gel to a final con-containing 2 mM EDTA was then injected into the lumen of the intact
centration of 15% to minimize band broadening. The radiolabeledcyst. After a 20 min incubation, the cyst was massaged several times
PCR products were initially denatured by heating at 958C for 5 min-to assist in detachment of the epithelial cells from the basement
utes and then allowed to cool to room temperature gradually overmembrane. Cysts that maintained the extraction solution (PBS/
1–2 hr before loading. Gels were run at 700 V for 14–16 hr, dried,EDTA) in their lumina for the duration of the incubation period were
and placed on X-Omat XAR film (Kodak) at room temperature or onconsidered intact. Only the epithelial cells of intact cysts were har-
a Phosphoimager cassette (Molecular Dynamics).vested by drainage. The cystic epithelial cells in the extraction solu-
tion (PBS/EDTA) and the last wash solutions were centrifuged at
1500 rpm (Beckman) for 15 min. The pellet was used for DNA prepa- Mixing Studies
ration using the Puregene DNA extraction kit (Gentra) according to The polymorphic locus EJ1 was identified by heteroduplex analysis
the manufacturer’s protocol. To assist in DNA precipitation, 10 mg using the primers FQF28–FQR35 as described above. This PCR
of glycogen was added to each sample. product spans part of exons 45 and 46 as well as the 90 bp intron
between them and contains the coiled-coil domain of polycystin.
Three heteroduplex patterns were detected in a screen of 20 normalClonality Assay
The DNA samples were digested with 10 units of HpaII or HhaI in and 45 affected individuals. The PCR products that gave each pat-
tern were cloned into pCRII (Invitrogen) and then sequenced toa volume of 10 ml overnight at 378C. The enzyme was inactivated
by heating at 958C for 10 min and then used directly as template determine the molecular basis for the polymorphism. A1 was found
to contain the published sequence (HUMPKD1A, GenBank acces-for PCR amplification. A set of control amplifications without prior
restriction digestion was done in parallel using identical reaction sion number L33243), whereas A2 had a conservative base pair
change (C-to-T) at position 12,617, which did not alter the aminoconditions for samples from donors JHU93, JHU188, JHU244, and
JHU304. In all cases, two alleles were amplified from each sample. acid sequence (leucine, amino acid 4136). A3 had eight consecutive
guanines in intron 45 instead of the seven contained in the publishedPCR was performed for 28 cycles of 948C for 20 sec, 658C for 20
sec, and 728C for 20 sec after an initial denaturation at 948 for 5 genomic sequence (51,325–51,331; HUMPKD1GEN, GenBank ac-
cession number L39891). All three alleles were used for mixingminutes. The PCR mixture (40 ml) contained a final concentration of
10 mM of each androgen receptor primer (AR1 and AR2), 5 nM studies.
EJ1 was amplified from clones of each of the alleles using the32P–end-labeled AR1, 2 units of Taq DNA polymerase (Bio-Rad Labo-
ratories), and 2 mM MgCl2. The sequences of the primers were PCR conditions described above. Four microliters of radiolabeled
EJ1 amplifed using cyst DNA as template was mixed in separateobtained from sequences reported by Tilley et al. (1989): AR1,
59-GCTGTGAAGGTTGCTGTTCCTCAT-39 (bp 485–508; HUMARA, tubes with 4 ml of cold product derived from each of the three cloned
alleles. Heteroduplex analysis was performed as described above.GenBank accession number M21748), and AR2, 59-TCCAGAATCTG
TTCCAGAGCGTGC-39 (bp 230–253). The PCRproducts were diluted The products obtained using sample C12 as template were cloned
into pCRII and assayed using A1–A2 in mixing studies. Two indepen-with 53 volume of sequencing loading buffer (95% formamide, 10
mM EDTA [pH 8.0], 0.1%bromophenol blue, and 0.1% xylene cyanol dent clones containing the mutant allele were sequenced using
an automated sequencer (Applied Biosystems, Inc.) and standardFF) and separated in a 6% denaturing polyacrylamide gel. The dried
gel was examined by autoradiography using X-Omat XAR film (Ko- protocols.
The 2 bp deletion identified in the C12 mutant clones created adak) at 2808C overnight with an intensifying screen. An aliquot of
DNA from a male with a different number of CAG repeats at the new MwoI site. To test for the presence of this site, a nested 172
bp PCR product was amplified using primers C12F1 (59-CTCandrogen receptor locus (so that the alleles could be distinguished)
Cell
986
TGCCCAGGGTGCAGC-39, genomic position 51,350–51,367; HUM- polymorphic CAG repeat in the human androgen-receptor gene cor-
relates with X chromosome inactivation. Am. J. Hum. Genet. 51,PKD1GEN) and C12R1 (59-GAGGTGGAGGGGTGCGAG-39, cDNA
position 12,760–12,777; HUMPKD1A) and the following templates: 1229–1239.
peripheral blood leukocyte DNA of the same donor, plasmid DNA The American PKD1 Consortium (1995). Analysis of the genomic
containing the EJ1 alleles cloned from C12, and the original EJ1 sequence for the autosomal dominant polycystic kidney disease
products obtained from C12 in two independent reactions. PCR (PKD1) gene predicts the presence of a leucine-rich repeat. Hum.
products were digested with MwoI (New England Bio Labs) ac- Mol. Gen. 4, 575–582.
cording to the manufacturer’s specfications and analyzed on a 4%
Blyth, H., and Ockenden, B.G. (1971). Polycystic disease of kidneyNusieve gel (FMC Bioproducts).
and liver presenting in childhood. J. Med. Genet. 8, 257–284.
Bogdanova, N., Dworniczak, B., Dragova, D., Todorov, V., Dimitra-
Haplotype and Family Analysis kov, D., Kalinov, K., Hallmayer, J., Horst, J., and Kalaydjieva, L.
The allelic genomic fragments that include both the KG8 and EJ1 (1995). Genetic heterogeneity of polycystic kidney disease in Bul-
loci were amplified from each individual using the primers FQF28 garia. Hum. Genet. 95, 645–650.
and KG8R8 and 200 ng of peripheral blood leukocyte DNA as tem- Daoust, M.C., Reynolds, D.M., Bichet, D.G., and Somlo, S. (1995).
plate. The 50 ml reaction included 4 units of rTth DNA polymerase, Evidence for a third genetic locus for autosomal dominant polycystic
XL (Perkin Elmer), and a final concentration of 1.1 mM magnesium kidney disease. Genomics 25, 733–736.
acetate and was performed using the following conditions: 958C for
de Almeida, S., de Almeida, E., Peters, D., Pinto, J.R., Tavora, I.,3 min; 35 cycles of 958C for 20 sec and 688C for 2 min; and a final
Lavinha, J., Breuning, M., and Prata, M.M. (1995). Autosomal domi-extension of 688C for 10 min. The 1.6 kb products were cloned into
nant polycystic kidney disease-evidence for the existence of a thirdpCRII, and then individual clones were analyzed for the variants
locus in a Portuguese family. Hum. Genet. 96, 83–88.they contained at each locus using the microsatellite assay (KG8)
The European Polycystic Kidney Disease Consortium (1994). Theand mixing studies (EJ1) as described above.
polycystic kidney disease gene encodes a 14 kb transcript and liesFamily members of patients donating kidneys were recruited to
within a duplicated region on chromosome 16. Cell 77, 881–894.participate after receiving permission from the donors. Blood sam-
ples were obtained after receiving informed consent and according Evan, A.P., and McAteer, J.A. (1992). Cyst cells and cyst walls. In
to institutional guidelines. DNA was prepared from whole blood The Cystic Kidney, K.D. Gardner and J. Bernstein, eds. (London:
using the Puregene kit. The KG8 microsatellite assay was performed Kluwer Academic Publishers), pp. 21–41.
as described above. The marker 39HVR was also used to confirm Fearon, E.R., Hamilton, S.R., and Vogelstein, B. (1987). Clonal analy-
linkage of ADPKD to chromosome 16 markers. Five micrograms of sis of human colorectal tumors. Science 238, 193–197.
genomic DNA was digested with PvuII (New England Bio Labs),
Fick, G.M., Johnson, A.M., Strain, J.D., Kimberling, W.J., Kumar, S.,electrophoresed overnight through a 1% agarose gel, and then
Manco-Johnson, M.L., Duley, I.T., and Gabow, P.A. (1993). Charac-transferred to nylon membrane (Schleicher and Schuel) using stan-
teristics of very early onset autosomal dominant polycystic kidneydard Southern blot protocols. 39HVR was labeled using Rediprime
disease. J. Am. Soc. Nephrol. 3, 1863–1870.(Amersham) and hybridized to Southern blots in hybridization buffer
(0.5 M Na2HPO4 [pH 7.2], 1 mM EDTA, 1% BSA, and 7% SDS) at Fick, G.M., Johnson, A.M., and Gabow, P.A. (1994). Is there evidence
for anticipation in autosomal-dominant polycystic kidney diesease?668C. Blots were washed two or three times at 658C with 0.1% SSC,
0.1% SDS and imaged using a Phosphoimager screen (Molecular Kidney Int. 45, 1153–1162.
Dyanamics). Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek,
Two-point linkage analyses were performed using the MLINK pro- M. M., Crossey, P.A., Richards, F.M., Cairns, P., Affara, N.A., Fergu-
gram of the LINKAGE 5.1 package. The disease gene frequency son-Smith, M.A., et al. (1994). Somatic mutations of the von Hippel-
was set at 0.001 and penetrance set at 0.98 for individuals >30 Lindau disease tumour suppressor gene in non-familial clear cell
years old. Sex-averaged recombination fractions were used (0.05 renal carcinoma. Hum. Mol. Genet. 3, 2169–2173.
for 39HVR and 0.0 for KG8). The posterior probability of linkage to
Gabow, P.A (1993). Autosomal dominant polycystic kidney disease.PKD1 was determined for pedigree 1 (Figure 5A) using an estimate
N. Engl. J. Med. 329, 332–342.of the prior probability of linkage (a) of 0.85 (Narod, 1991; Peters and
Gilliland, D.G., Blanchard, K.L., Levy, J., Perrin, S., and Bunn, H.F.Sandkuijl, 1992; Ravine et al., 1992; Peters et al., 1993; Mochizuki et
(1991). Clonality in myeloproliferative disorders: analysis by meansal., 1996).
of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 88,
6848–6852.
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